Notable 52-Week Highs and Lows of the Day 09/05: (DIS) (LLY) (SRPT) High; (AMD) (AUQ) (ANR) Low

Go back to Notable 52-Week Highs and Lows of the Day 09/05: (DIS) (LLY) (SRPT) High; (AMD) (AUQ) (ANR) Low

AuRico Gold (AUQ) Slammed Following Ocampo Update; Sees Lower Production, Higher CapEx

September 5, 2012 11:47 AM EDT

AuRico Gold (NYSE: AUQ) is getting slammed Wednesday following an update provided by the miner for its Ocampo Mine site in Mexico.

Shares are over 19 percent lower on the session.

According to the release:

"As previously reported on July 16, 2012, production in the second quarter of 2012 was negatively impacted by an unusually high turnover of skilled labour that significantly reduced underground ore development in the... More

Goldman Sachs Boosts Numbers on CNO Financial (CNO) After Recapitalization Plan, Keeps Top Rating

September 5, 2012 10:22 AM EDT

Goldman Sachs reiterated its Conviction Buy List rating on CNO Financial Group (NYSE: CNO) and raised its price target from $10 to $11 following a recapitalization plan from the company.

CNO will enter a new senior secured credit agreement consisting of a $250mn... More

Raymond James Downgrades Alpha Natural Resources (ANR) to Outperform

September 5, 2012 8:52 AM EDT

Raymond James downgraded Alpha Natural Resources (NYSE: ANR) from Strong Buy to Outperform after lowering their met coal price forecast from $210/mt to $190 for Q4 and from $217.50 to $200 for 2013.

For an analyst ratings summary and ratings history on Alpha Natural Resources... More

Bernstein Upgrades Eli Lilly (LLY) to Outperform

September 5, 2012 7:37 AM EDT

Bernstein upgraded Eli Lilly (NYSE: LLY) from Market Perform to Outperform with a price target of $52.00 (from $46.00).

The firm noted solanezumab could become a marketed product for Alzheimer's, phase 3 pileline among fullest vs. peers, Alimta patent challenge could add upside if they... More

UPDATE: UBS Downgrades AMD (AMD) to Neutral; Cutting Numbers on Competitive Challenges

September 5, 2012 7:32 AM EDT

(Updated - September 5, 2012 9:54 AM EDT)

UBS downgraded AMD (NYSE: AMD) from Buy to Neutral. PT lowered from $6.25 to $4.00.

Analyst, Steven Eliscu, said, "We lower our AMD out-year estimates, PT and downgrade to Neutral for 5 key reasons: 1) Shrinking PC client... More

Sarepta Therapeutics (SRPT) Enters $40M At-The-Market Agreement with Citadel

September 4, 2012 5:07 PM EDT

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) filed a registration with the U.S. SEC to sell, from time to time, up to $40 million of its common stock.

The filing comes as Sarepta entered an at-the-market equity offering sales agreement with Citadel Securities LLC.... More

Dahlman Rose Downgrades BTU, ANR & WLT; Reiterates 'Buy' on CNX, CLD & ACI

September 4, 2012 3:18 PM EDT

This morning, Dahlman Rose downgraded Peabody (NYSE: BTU), Alpha Natural Resources (NYSE: ANR) and Walter Energy (NYSE: WLT) from Buy to Hold, saying these three names have the most metallurgical coal... More